The UK private GP EHR market is predicted to grow due to stronger demand for private GP services and advancements in healthcare tech, according to a report by ResearchAndMarkets. A decline in NHS GPs and a lack of primary care physicians have helped the number of Google searches for private GPs to surge 156% between 2019 and 2022. Integration of AI and EHRs is also set to boost the market.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
